Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Insights into Imaging
Published in: Insights into Imaging 1/2020

01-12-2020 | Ultrasound | Educational Review

CEUS LI-RADS: a pictorial review

Authors: Tommaso Vincenzo Bartolotta, Maria Chiara Terranova, Cesare Gagliardo, Adele Taibbi

Published in: Insights into Imaging | Issue 1/2020

Login to get access

Abstract

Contrast-enhanced ultrasound (CEUS) greatly improved the diagnostic accuracy of US in the detection and characterization of focal liver lesions (FLLs), and it is suggested and often included in many international guidelines as an important diagnostic tool in the imaging work-up of cirrhotic patients at risk for developing hepatocellular carcinoma (HCC). In particular, CEUS Liver Imaging Reporting and Data System (LI-RADS) provides standardized terminology, interpretation, and reporting for the diagnosis of HCC. The aim of this pictorial essay is to illustrate CEUS features of nodules discovered at US in cirrhotic liver according to LI-RADS categorization.
Literature
1.
2.
European Association for the Study of the Liver (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. European Association for the Study of the Liver. J Hepatol 69(1):182–236
3.
Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380CrossRef
4.
Omata M, Cheng AL, Kokudo N et al (2017) Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int 11:317–370PubMedCrossRef
5.
Thomsen HS (2009) Nephrogenic systemic fibrosis: history and epidemiology. Radiol Clin North Am 47:827–831PubMedCrossRef
6.
Tao SM, Wichmann JL, Schoepf UJ, Fuller SR, Lu GM, Zhang LJ (2016) Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention. Eur Radiol 26:3310–3318PubMedCrossRef
7.
Bartolotta TV, Taibbi A, Midiri M, La Grutta L, De Maria M, Lagalla R (2010) Characterisation of focal liver lesions undetermined at grey-scale US: contrast-enhanced US versus 64-row MDCT and MRI with liver-specific contrast agent. Radiol Med 115(5):714–731PubMedCrossRef
8.
Bartolotta TV, Taibbi A, Midiri M, Lagalla R (2009) Focal liver lesions: contrast-enhanced ultrasound. Abdom Imaging 34(2):193–209PubMedCrossRef
9.
Bartolotta TV, Vernuccio F, Taibbi A, Lagalla R (2016) Contrast-enhanced ultrasound in focal liver lesions: where do we stand? Semin Ultrasound CT MR 37(6):573–586PubMedCrossRef
10.
Wilson SR, Burns PN (2010) Microbubble-enhanced US in body imaging: what role? Radiology 257(1):24–39PubMedCrossRef
11.
Wilson SR, Kim TK, Jang HJ, Burns PN (2007) Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol 189(1):W7–W12PubMedCrossRef
12.
Mauri G, Porazzi E, Cova L et al (2014) Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging 5(2):209–216PubMedPubMedCentralCrossRef
13.
Seinstra BA, van Delden OM, van Erpecum KJ, van Hillegersberg R, Willem PT, van den Bosch MA (2010) Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: what is the evidence today? Insights Imaging 1(3):167–181PubMedPubMedCentralCrossRef
14.
15.
Bartolotta TV, Midiri M, Quaia E et al (2005) Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 15(8):1643–1649PubMedCrossRef
16.
Bartolotta TV, Taibbi A, Midiri M, De Maria M (2008) Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound. Abdom Imaging 33:501–551PubMedCrossRef
17.
Bartolotta TV, Taibbi A, Matranga D, Midiri M, Lagalla R (2015) 3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings. Radiol Med 120(8):695–704PubMedCrossRef
18.
Bartolotta TV, Taibbi A, Matranga D et al (2012) Incidence of new foci of hepatocellular carcinoma after radiofrequency ablation: role of multidetector CT. Radiol Med 117(5):739–748PubMedCrossRef
19.
Dietrich CF, Averkiou M, Nielsen MB et al (2018) How to perform contrast-enhanced ultrasound (CEUS). Ultrasound Int Open 4(01):E2–15
20.
Jo PC, Jang HJ, Burns PN, Burak KW, Kim TK, Wilson SR (2017) Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: how I do it. Radiology 282(2):317–331PubMedCrossRef
21.
Wu M, Li L, Wang J et al (2018) Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis. Eur Radiol 28(5):2077–2088PubMedCrossRef
22.
23.
Piscaglia F, Bolondi L (2006) The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32:1369–1375PubMedCrossRef
24.
Westwood M, Joore M, Grutters J et al (2013) Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess 17(16):1–243. https://​doi.​org/​10.​3310/​hta17160
25.
Lorusso A, Quaia E, Poillucci G, Stacul F, Grisi G, Cova MA (2015) Activity-based cost analysis of contrast-enhanced ultrasonography (CEUS) related to the diagnostic impact in focal liver lesion characterisation. Insights Imaging 6(4):499–508PubMedPubMedCentralCrossRef
26.
Bartolotta TV, Taibbi A, Midiri M, Matranga D, Solbiati L, Lagalla R (2011) Indeterminate focal liver lesions incidentally discovered at gray-scale US: role of contrast-enhanced sonography. Invest Radiol 46(2):106–115PubMedCrossRef
27.
Claudon M, Dietrich CF, Choi BI et al (2013) World Federation for Ultrasound in Medicine; European Federation of Societies for Ultrasound. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 39(2):187–210
28.
29.
Elsayes KM, Hooker JC, Agrons MM et al (2017) 2017 version of LI-RADS for CT and MR imaging: an update. Radiographics 37:1994–2017PubMedCrossRef
30.
Wilson SR, Lyshchik A, Piscaglia F et al (2018) CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Abdom Radiol (NY) 43(1):127–142CrossRef
31.
Kambadakone AR, Fung A, Gupta RT et al (2018) LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Abdominal Radiol 43(1):56–74CrossRef
32.
Piscaglia F, Wilson SR, Lyshchik A et al (2017) American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for the diagnosis of hepatocellular carcinoma: a pictorial essay. Ultraschall Med 38(03):320–324PubMedCrossRef
33.
Lyshchik A, Kono Y, Dietrich CF et al (2018) Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group. Abdom Radiol (NY) 43(4):861–879CrossRef
34.
Maruyama H, Takahashi M, Ishibashi H, Yoshikawa M, Yokosuka O (2012) Contrast enhanced ultrasound for characterisation of hepatic lesions appearing non hypervascular on CT in chronic liver diseases. Br J Radiol 85:351–357PubMedPubMedCentralCrossRef
35.
Takahashi M, Maruyama H, Shimada T et al (2013) Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging. Eur J Radiol 82(1):75–84PubMedCrossRef
36.
Sugimoto K, Moriyasu F, Shiraishi J et al (2012) Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging. Eur Radiol 22(6):1205–1213PubMedCrossRef
37.
Bhayana D, Kim TK, Jang HJ, Burns PN, Wilson SR (2010) Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout. AJR Am J Roentgenol 194:977–983PubMedCrossRef
38.
Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 244(3):898–906PubMedCrossRef
39.
Tang A, Valasek MA, Sirlin CB (2015) Update on the liver imaging reporting and data system: what the pathologist needs to know. Adv Anat Pathol 22(5):314–322PubMedCrossRef
40.
Quaia E, Bartolotta TV, Midiri M, Cernic S, Belgrano M, Cova M (2006) Analysis of different contrast enhancement patterns after microbubble-based contrast agent injection in liver hemangiomas with atypical appearance on baseline scan. Abdom Imaging 31(1):59–64PubMedCrossRef
41.
Bartolotta TV, Midiri M, Quaia E et al (2005) Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US. Eur Radiol 15(4):685–693PubMedCrossRef
42.
Bartolotta T, Midiri M, Galia M A et al (2003) Atypical liver hemangiomas: contrast-enhancement patterns with SH U 508A and pulse-inversion US. Radiol Med 106(4):320–328
43.
Bartolotta TV, Taibbi A, Galia M et al (2007) Centrifugal (inside-out) enhancement of liver hemangiomas: a possible atypical appearance on contrast-enhanced US. Eur J Radiol 64(3):447–455PubMedCrossRef
44.
Bartolotta TV, Midiri M, Galia M et al (2007) Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US. Abdom Imaging 32(1):84–91PubMedCrossRef
45.
Bartolotta TV, Taibbi A, Galia M et al (2007) Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: diagnostic performance and confidence of contrast-enhanced ultrasound. Eur Radiol 17(3):650–661PubMedCrossRef
46.
Bartolotta TV, Taibbi A, Picone D, Anastasi A, Midiri M, Lagalla R (2017) Detection of liver metastases in cancer patients with geographic fatty infiltration of the liver: the added value of contrast-enhanced sonography. Ultrasonography 36(2):160–169PubMedCrossRef
47.
Kim TK, Lee KH, Khalili K, Jang HJ (2011) Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound. Abdom Imaging 36(3):244–263PubMedCrossRef
48.
Khanna M, Ramanathan S, Fasih N, Schieda N, Virmani V, McInnes MD (2015) Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma. Insights Imaging 6(3):347–362PubMedPubMedCentralCrossRef
49.
Taibbi A, Brancatelli G, Matranga D, Midiri M, Lagalla R, Bartolotta TV (2019) Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI. Diagn Interv Radiol 25(2):95–101PubMedPubMedCentralCrossRef
50.
Giambelluca D, Taibbi A, Midiri M, Bartolotta TV (2019) The “spoke wheel” sign in hepatic focal nodular hyperplasia. Abdom Radiol (NY) 44(3):1183–1184CrossRef
51.
Sandonato L, Cipolla C, Graceffa G et al (2007) Giant hepatocellular adenoma as cause of severe abdominal pain: a case report. J Med Case Rep 27(1):57
52.
Bartolotta TV, Midiri M, Scialpi M, Sciarrino E, Galia M, Lagalla R (2004) Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 14(4):583–591PubMedCrossRef
53.
Bartolotta TV, Taibbi A, Matranga D, Malizia G, Lagalla R, Midiri M (2010) Hepatic focal nodular hyperplasia: contrast-enhanced ultrasound findings with emphasis on lesion size, depth and liver echogenicity. Eur Radiol 20(9):2248–2256PubMedCrossRef
54.
Bartolotta TV, Taibbi A, Brancatelli G et al (2014) Imaging findings of hepatic focal nodular hyperplasia in men and women: are they really different? Radiol Med 119(4):222–230PubMedCrossRef
55.
Wildner D, Bernatik T, Greis C, Seitz K, Neurath MF, Strobel D (2015) CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial. Ultraschall Med 36(2):132–139PubMedCrossRef
56.
Chen LD, Ruan SM, Liang JY et al (2018) Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: a predictive model using contrast-enhanced ultrasound. World J Gastroenterol 24(33):3786–3798PubMedPubMedCentralCrossRef
57.
Vilana R, Forner A, Bianchi L et al (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display avascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology. 51(6):2020–2029PubMedCrossRef
58.
Han J, Liu Y, Han F et al (2015) The degree of contrast washout on contrast-enhanced ultrasound in distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma. Ultrasound Med Biol 41(12):3088–3095CrossRef
59.
de Sio I, Iadevaia MD, Vitale LM et al (2014) Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: a single-center retrospective study. United European Gastroenterol J 2(4):279–287
60.
61.
62.
Galia M, Taibbi A, Marin D et al (2014) Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? Diagn Interv Radiol 20(3):222–228PubMedPubMedCentralCrossRef
63.
64.
65.
Jang HJ, Kim TK, Burns PN, Wilson SR (2015) CEUS: an essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma. Eur J Radiol 84(9):1623–1635PubMedCrossRef
66.
Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH (2006) Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 12(13):2115–2119PubMedPubMedCentralCrossRef
67.
Raza SA, Jang HJ, Kim TK (2014) Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound. Abdom Imaging 39:153–161PubMedCrossRef
68.
69.
Cassinotto C, Aubé C, Dohan A (2017) Diagnosis of hepatocellular carcinoma: an update on international guidelines. Diagn Interv Imaging 98(5):379–391PubMedCrossRef
Metadata
Title
CEUS LI-RADS: a pictorial review
Authors
Tommaso Vincenzo Bartolotta
Maria Chiara Terranova
Cesare Gagliardo
Adele Taibbi
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 1/2020
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1186/s13244-019-0819-2

Other articles of this Issue 1/2020

Insights into Imaging 1/2020 Go to the issue

Educational Review

Magnetic resonance imaging of the female pelvis after Cesarean section: a pictorial review

Original Article

The 100 top-cited meta-analyses of diagnostic accuracy in radiology journals: a bibliometric analysis

Educational Review

Cortical ischaemic patterns in term partial-prolonged hypoxic-ischaemic injury—the inter-arterial watershed demonstrated through atrophy, ulegyria and signal change on delayed MRI scans in children with cerebral palsy

Statement

The Current Status of Radiological Clinical Audit and Feedback on the ESR Guide to Clinical Audit in Radiology and the ESR Clinical Audit Tool (Esperanto) – an ESR Survey of European Radiology Departments

Educational Review

Imaging of the aortic root on high-pitch non-gated and ECG-gated CT: awareness is the key!

Original Article

Structured reporting of chest CT in COVID-19 pneumonia: a consensus proposal